The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT.	Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease	Active, not recruiting	Not applicable	2025-11-17		NCT05797714

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jiangsu Hansoh Pharmaceutical Co., Ltd.	59
Ruijin Hospital	454

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing You'An Hospital, Capital Medical University	Beijing	China	2
Fuyang Second People's Hospital	Fuyang	China	2
Jiangsu Province Hospital	Nanjin	China	1
LiShui People's Hospital of Zhejiang Province	Lishui	China	1
People's Hospital of Dongyang City	Dongyang	China	1
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.	Shanghai	China	1
Shanghai East Hospital	Shanghai	China	33
The Fifth People's Hospital of Suzhou	Suzhou	China	1
The Fifth People's Hospital of Wuxi	Wuxi	China	1
The First Affiliated Hospital of Nanchang University	Nanchang	China	55
The First People's Hospital of Xiaoshan District, Hangzhou, Zhejiang Province	Hangzhou	China	1
The Second Xiangya Hospital, Central South University	Changsha	China	1